SE8900192D0 - Dideoxididehydrokarbocykliska nukleosider - Google Patents

Dideoxididehydrokarbocykliska nukleosider

Info

Publication number
SE8900192D0
SE8900192D0 SE8900192A SE8900192A SE8900192D0 SE 8900192 D0 SE8900192 D0 SE 8900192D0 SE 8900192 A SE8900192 A SE 8900192A SE 8900192 A SE8900192 A SE 8900192A SE 8900192 D0 SE8900192 D0 SE 8900192D0
Authority
SE
Sweden
Prior art keywords
dideoxidide
hydrocarbocyclic
nucleosides
compounds
nrr1
Prior art date
Application number
SE8900192A
Other languages
English (en)
Other versions
SE505213C2 (sv
SE8900192L (sv
Inventor
R Vince
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/146,252 external-priority patent/US4916224A/en
Priority claimed from GB888821011A external-priority patent/GB8821011D0/en
Priority claimed from US07/278,652 external-priority patent/US4931559A/en
Application filed by Univ Minnesota filed Critical Univ Minnesota
Publication of SE8900192D0 publication Critical patent/SE8900192D0/sv
Publication of SE8900192L publication Critical patent/SE8900192L/sv
Publication of SE505213C2 publication Critical patent/SE505213C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SE8900192A 1988-01-20 1989-01-19 Dideoxikarbocykliska nukleosidanaloger, farmaceutiska beredningar därav samt mellanprodukter SE505213C2 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/146,252 US4916224A (en) 1988-01-20 1988-01-20 Dideoxycarbocyclic nucleosides
GB888821011A GB8821011D0 (en) 1988-09-07 1988-09-07 Chemical compounds
US07/278,652 US4931559A (en) 1988-01-20 1988-12-05 Optically-active isomers of dideoxycarbocyclic nucleosides

Publications (3)

Publication Number Publication Date
SE8900192D0 true SE8900192D0 (sv) 1989-01-19
SE8900192L SE8900192L (sv) 1989-07-21
SE505213C2 SE505213C2 (sv) 1997-07-14

Family

ID=27264063

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8900192A SE505213C2 (sv) 1988-01-20 1989-01-19 Dideoxikarbocykliska nukleosidanaloger, farmaceutiska beredningar därav samt mellanprodukter

Country Status (29)

Country Link
JP (1) JP2793825B2 (sv)
KR (1) KR0127137B1 (sv)
AT (1) AT397801B (sv)
AU (2) AU626278B2 (sv)
BE (1) BE1003815A4 (sv)
CA (1) CA1339896C (sv)
CH (1) CH679152A5 (sv)
DE (1) DE3901502C2 (sv)
DK (1) DK175131B1 (sv)
ES (1) ES2010091A6 (sv)
FI (1) FI93546C (sv)
FR (1) FR2626002B1 (sv)
GB (1) GB2217320B (sv)
GR (1) GR890100033A (sv)
HU (1) HU203755B (sv)
IE (1) IE62275B1 (sv)
IL (1) IL88999A (sv)
IT (1) IT1229531B (sv)
LU (1) LU87437A1 (sv)
MY (1) MY103801A (sv)
NL (1) NL8900122A (sv)
NO (1) NO169123C (sv)
NZ (1) NZ227663A (sv)
OA (1) OA09031A (sv)
PL (1) PL163814B1 (sv)
PT (1) PT89482B (sv)
RU (1) RU2114846C1 (sv)
SE (1) SE505213C2 (sv)
YU (1) YU47791B (sv)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1215339B (it) * 1987-01-14 1990-02-08 Co Pharma Corp Srl Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US4939252A (en) * 1989-04-20 1990-07-03 Hoffmann-La Roche Inc. Novel intermediates for the preparation of Carbovir
DE69033252T2 (de) * 1989-06-27 1999-12-09 The Wellcome Foundation Ltd., Greenford Therapeutische nukleoside
GB8916477D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916478D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916479D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916480D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5144034A (en) * 1990-04-06 1992-09-01 Glaxo Inc. Process for the synthesis of cyclopentene derivatives of purines
US5057630A (en) * 1990-04-06 1991-10-15 Glaxo Inc. Synthesis of cyclopentene derivatives
US5126452A (en) * 1990-04-06 1992-06-30 Glaxo Inc. Synthesis of purine substituted cyclopentene derivatives
US5241069A (en) * 1990-04-06 1993-08-31 Glaxo Inc. Carbonate intermediates for the synthesis of purine substituted cyclopentene derivatives
GB9108376D0 (en) * 1991-04-19 1991-06-05 Enzymatix Ltd Cyclopentenes
HUT74989A (en) * 1993-11-12 1997-03-28 Merrell Pharma Inc 6-oxo-nucleosides useful as immunosuppressants
GB9721780D0 (en) 1997-10-14 1997-12-10 Glaxo Group Ltd Process for the synthesis of chloropurine intermediates
ATE240945T1 (de) * 1998-10-30 2003-06-15 Lonza Ag Verfahren zur herstellung von 4-((2',5'-diamino- 6'-halogenpyrimidin-4'-yl)amino)-cyclopent-2- enylmethanolen
KR100606625B1 (ko) 1998-10-30 2006-07-28 론자 아게 4-[(2',5'-디아미노-6'-할로피리미딘-4'-일)아미노]-시클로펜트-2-에닐메탄올의 제조 방법
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB9903091D0 (en) * 1999-02-12 1999-03-31 Glaxo Group Ltd Therapeutic nucleoside compound
AR039540A1 (es) * 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
JP7104154B2 (ja) 2018-07-27 2022-07-20 富士フイルム株式会社 シクロペンテニルプリン誘導体またはその塩
JP2023519882A (ja) 2020-03-27 2023-05-15 ソム、イノベーション、バイオテック、ソシエダッド、アノニマ シヌクレイノパチーの治療に有用な化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268672A (en) * 1977-02-09 1981-05-19 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
JPS62177234A (ja) * 1986-01-30 1987-08-04 Mitsubishi Heavy Ind Ltd 遠心紡糸によるカ−ボン繊維の製造装置
IN164556B (sv) * 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.

Also Published As

Publication number Publication date
HUT48887A (en) 1989-07-28
ES2010091A6 (es) 1989-10-16
DK175131B1 (da) 2004-06-14
GB2217320B (en) 1992-04-08
NO890253D0 (no) 1989-01-19
FI890286A0 (sv) 1989-01-19
GB2217320A (en) 1989-10-25
NZ227663A (en) 1990-09-26
JP2793825B2 (ja) 1998-09-03
GR890100033A (el) 1994-03-31
NO890253L (no) 1989-07-21
RU2114846C1 (ru) 1998-07-10
AU626278B2 (en) 1992-07-30
JPH02196788A (ja) 1990-08-03
AU2867189A (en) 1989-07-20
NO169123B (no) 1992-02-03
AT397801B (de) 1994-07-25
IE62275B1 (en) 1995-01-25
NO169123C (no) 1992-05-13
ATA10689A (de) 1993-11-15
AU637015B2 (en) 1993-05-13
BE1003815A4 (fr) 1992-06-23
MY103801A (en) 1993-09-30
IE890153L (en) 1989-07-20
IL88999A0 (en) 1989-08-15
SE505213C2 (sv) 1997-07-14
DE3901502A1 (de) 1989-07-27
FI93546C (sv) 1995-04-25
IT1229531B (it) 1991-09-04
AU1018092A (en) 1992-03-12
PL163814B1 (en) 1994-05-31
DK23489D0 (da) 1989-01-19
KR0127137B1 (ko) 1997-12-29
IL88999A (en) 1994-12-29
YU12389A (en) 1991-10-31
YU47791B (sr) 1996-01-09
KR890011902A (ko) 1989-08-23
FI93546B (sv) 1995-01-13
HU203755B (en) 1991-09-30
DK23489A (da) 1989-07-21
FR2626002A1 (fr) 1989-07-21
GB8901187D0 (en) 1989-03-15
OA09031A (en) 1991-03-31
FI890286A (sv) 1989-07-21
CH679152A5 (sv) 1991-12-31
FR2626002B1 (fr) 1994-01-28
LU87437A1 (fr) 1989-08-30
IT8947546A0 (it) 1989-01-19
NL8900122A (nl) 1989-08-16
PL277261A1 (en) 1989-09-18
DE3901502C2 (de) 2002-06-13
PT89482A (pt) 1989-10-04
CA1339896C (en) 1998-06-02
PT89482B (pt) 1994-02-28
SE8900192L (sv) 1989-07-21

Similar Documents

Publication Publication Date Title
SE8900192L (sv) Dideoxididehydrokarbocykliska nukleosider
NO883506D0 (no) Fremgangsmaate for fremstilling av foretrede polyoksyalkylenderivater.
RU92004364A (ru) Дидезоксидидегидрокарбоциклические нуклеозиды
NO169900C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (ih-azol-1-ylmetyl)substituerte benzotriazolderivater
NO170155C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO862956L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-derivater.
DE68903226D1 (de) Dideoxydidehydrocarbocyclische nukleoside.
LU88790I2 (fr) Moxidectin et ses dérivés pharmaceutiquement acceptables
NO151287C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9-hydrazono-6,7,8,9-tetrahydro-4h-pyrido(1,2-a)-pyrimidinderivater
NO933611L (no) Anti-tumor- og anti-psoriatiske midler
NO871044D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater.
DK584288A (da) Fremgangsmaade til fremstilling af guaninderivater
NO173503C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydroimidayo (1,4) benzodiazepin-2-tioner
NO169966C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-substituerte pyrazolo(3,4-d)pyrimidinderivater
NO167734C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater.
FR2434167A1 (fr) Derives de l'hexahydro-1,2,3,3a,8,8a pyrrolo indole (2,3,-b)
NO167028C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo(3,4-d)pyrimidinderivater
IT1197516B (it) Derivati teofillinmetilanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
NO173606C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno- triazolo-diazepin-derivater
NO169442C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive prolinderivater og lignende forbindelser
FR2618435B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
DK0607129T3 (da) Methylpiperazinoazepinderivater, deres fremstilling og deres anvendelse
ATE38677T1 (de) Derivate von cyanoimidazol-nukleosiden.
NO150280C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 9-aminopyrido(1,2-a)pyrimidinderivater

Legal Events

Date Code Title Description
NUG Patent has lapsed